Grifols is a global healthcare company that specializes in the production of medicines derived from human plasma, the liquid portion of blood. Plasma contains many proteins that are essential for normal physical and neurologic function. Patients around the world rely on our plasma-derived medicines to treat rare and life-threatening conditions such as immune deficiencies, hemophilia, genetic emphysema, and other diseases that cannot be adequately treated with traditional pharmaceutical drugs.
To ensure a continuous supply of plasma medicines, Grifols operates 145 plasma donation centers around the nation. Individuals who donate their plasma are providing the source material for our unique medicines, and we are proud of the contributions they make toward improving the health and well being of patients worldwide. We invite you to explore our website to learn more about how you can help save lives by donating plasma.
Talecris Plasma Resources, Inc. is a wholly owned subsidiary of Grifols, Inc.